Authors:
Frasci, G
Nicolella, G
Comella, P
Carreca, I
DeCataldis, G
Muci, D
Brunetti, C
Natale, M
Piantedosi, F
Russo, A
Palmeri, S
Comella, G
Panza, N
Citation: G. Frasci et al., A weekly regimen of cisplatin, paclitaxel and topotecan with granulocyte-colony stimulating factor support for patients with extensive disease small cell lung cancer: a phase II study, BR J CANC, 84(9), 2001, pp. 1166-1171
Authors:
Comella, P
Frasci, G
Panza, N
Manzione, L
De Cataldis, G
Cioffi, R
Maiorino, L
Micillo, E
Lorusso, V
Di Rienzo, G
Filippelli, G
Lamberti, A
Natale, M
Bilancia, D
Nicolella, G
Di Nota, A
Comella, G
Citation: P. Comella et al., Randomized trial comparing cisplatin, gemcitabine, and vinorelbine with either cisplatin and gemcitabine or cisplatin and vinorelbine in advanced non-small-cell lung cancer: Interim analysis of a phase III trial of the southern Italy Cooperative Oncology Group, J CL ONCOL, 18(7), 2000, pp. 1451-1457
Authors:
Lorusso, V
Carpagnano, F
Frasci, G
Panza, N
Di Rienzo, G
Cisternino, ML
Napoli, G
Orlando, S
Cinieri, S
Brunetti, C
Palazzo, S
De Lena, M
Citation: V. Lorusso et al., Phase I/II study of gemcitabine plus vinorelbine as first-line chemotherapy of non-small-cell lung cancer, J CL ONCOL, 18(2), 2000, pp. 405-411
Authors:
Frasci, G
Lorusso, V
Panza, N
Comella, P
Nicolella, G
Bianco, A
De Cataldis, G
Iannelli, A
Bilancia, D
Belli, M
Massidda, B
Piantedosi, F
Comella, G
De Lena, M
Citation: G. Frasci et al., Gemcitabine plus vinorelbine versus vinorelbine alone in elderly patients with advanced non-small-cell lung cancer, J CL ONCOL, 18(13), 2000, pp. 2529-2536
Citation: G. Rosati et al., Second-line chemotherapy with paclitaxel, cisplatin and gemcitabine in pre-treated sensitive cisplatin-based patients with advanced non-small cell lung cancer, ANTICANC R, 20(3B), 2000, pp. 2229-2233
Authors:
Baraldi, E
Dario, C
Ongaro, R
Scollo, M
Azzolin, NM
Panza, N
Paganini, N
Zacchello, F
Citation: E. Baraldi et al., Exhaled nitric oxide concentrations during treatment of wheezing exacerbation in infants and young children, AM J R CRIT, 159(4), 1999, pp. 1284-1288
Authors:
Frasci, G
Panza, N
Comella, P
Carteni, G
Guida, T
Nicolella, GP
Natale, M
Lombardi, R
Apicella, A
Pacilio, C
Gravina, A
Lapenta, L
Comella, G
Citation: G. Frasci et al., Cisplatin-topotecan-paclitaxel weekly administration with G-CSF support for ovarian and small-cell lung cancer patients: A dose-finding study, ANN ONCOL, 10(3), 1999, pp. 355-358
Authors:
Panza, N
Rambaldi, PF
Battista, C
Ambrosio, G
Cascini, GL
Schilliro, F
Mansi, L
Citation: N. Panza et al., Receptor imaging with In-111-pentreotide and(123)I-methoxybenzamide, and inhibition tests with octreotide and bromocriptine of mixed growth hormone/prolactin-secreting pituitary tumors, BIOMED PHAR, 53(7), 1999, pp. 319-322
Authors:
Frasci, G
Panza, N
Cornella, P
Nicolella, GP
Natale, M
Manzione, L
Bilancia, D
Cioffi, R
Maiorino, L
De Cataldis, G
Belli, M
Micillo, E
Mascia, V
Massidda, B
Lorusso, V
De Lena, M
Carpagnano, F
Contu, A
Pusceddu, G
Comella, G
Citation: G. Frasci et al., Cisplatin, gemcitabine, and paclitaxel in locally advanced or metastatic non-small-cell lung cancer: A phase I-II study, J CL ONCOL, 17(8), 1999, pp. 2316-2325
Authors:
Comella, P
Frasci, G
Panza, N
Manzione, L
Lorusso, V
Di Rienzo, G
Cioffi, R
De Cataldis, G
Maiorino, L
Bilancia, D
Nicolella, G
Natale, M
Carpagnano, F
Pacilio, C
De Lena, M
Bianco, A
Comella, G
Citation: P. Comella et al., Cisplatin, gemcitabine, and vinorelbine combination therapy in advanced non-small-cell lung cancer: A phase II randomized study of the Southern ItalyCooperative Oncology Group, J CL ONCOL, 17(5), 1999, pp. 1526-1534
Authors:
Aragona, F
Panza, N
Mangano, A
Castellucci, E
Capizzi, A
Citation: F. Aragona et al., No evidence of fluid absorption during continuous low-pressure transurethral resection of the prostate: Assessment by measuring expiratory breath ethanol concentrations, EUR UROL, 36(2), 1999, pp. 103-106